The U.S. Food and Drug Administration announced last week that it would remove the “black box” warning labels on hormone therapy for menopause.These labels, which show up on medication packaging, warn of the risks of heart attack, breast cancer, stroke and blood clots. But the FDA now says these risks are based on outdated science.Tuesday on Midday Edition, we hear what this could mean for menopause treatment going forward, and what to know about hormone therapy more broadly.Guest:Dr. Kathryn Macaulay, clinical professor, OB-GYN, director of UC San Diego Menopause Health programResources mentioned:The Menopause Society